| Dr Malak Waheb Yossef Iskandar, DO | |
|
3959 Electric Rd Ste 280, Roanoke, VA 24018-4572 | |
| (540) 427-7944 | |
| (540) 427-7945 |
| Full Name | Dr Malak Waheb Yossef Iskandar |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 13 Years |
| Location | 3959 Electric Rd Ste 280, Roanoke, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841581295 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 0102203991 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alleghany Highlands Community Services | 0840392544 | 4 |
| Blue Ridge Behavioral Healthcare | 6709831522 | 12 |
| Mental Wellness Group Pllc | 8729394762 | 2 |
News Archive
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB: RMCP), producers of the Rev Vac safety syringe, today announced that it has engaged Cirrus Financial Communications, LLC ("Cirrus") to provide comprehensive financial marketing and investor relations services.
Eye research charity Fight for Sight is partnering with the Stroke Association to test the effectiveness of a treatment for ‘retraining' the eyes for people who experience a loss of vision after stroke. The study hopes to establish a new standard of care for stroke survivors and save the NHS money.
APEIRON Biologics AG announced that it has entered into an exclusive option to license from the Cleveland Clinic a number of novel compounds. These compounds are currently in development at Cleveland Clinic as drug candidates for treatment of various cancers, designed to fight cancer based on stimulation of the immune system. In preclinical models, they have shown anti-cancer activity and a favourable toxicity profile as orally available agents.
› Verified 5 days ago
| Entity Name | Kuumba Community Health & Wellness Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205815420 PECOS PAC ID: 1052308632 Enrollment ID: O20040427000330 |
News Archive
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB: RMCP), producers of the Rev Vac safety syringe, today announced that it has engaged Cirrus Financial Communications, LLC ("Cirrus") to provide comprehensive financial marketing and investor relations services.
Eye research charity Fight for Sight is partnering with the Stroke Association to test the effectiveness of a treatment for ‘retraining' the eyes for people who experience a loss of vision after stroke. The study hopes to establish a new standard of care for stroke survivors and save the NHS money.
APEIRON Biologics AG announced that it has entered into an exclusive option to license from the Cleveland Clinic a number of novel compounds. These compounds are currently in development at Cleveland Clinic as drug candidates for treatment of various cancers, designed to fight cancer based on stimulation of the immune system. In preclinical models, they have shown anti-cancer activity and a favourable toxicity profile as orally available agents.
› Verified 5 days ago
| Entity Name | Blue Ridge Behavioral Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437137734 PECOS PAC ID: 6709831522 Enrollment ID: O20050315000430 |
News Archive
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB: RMCP), producers of the Rev Vac safety syringe, today announced that it has engaged Cirrus Financial Communications, LLC ("Cirrus") to provide comprehensive financial marketing and investor relations services.
Eye research charity Fight for Sight is partnering with the Stroke Association to test the effectiveness of a treatment for ‘retraining' the eyes for people who experience a loss of vision after stroke. The study hopes to establish a new standard of care for stroke survivors and save the NHS money.
APEIRON Biologics AG announced that it has entered into an exclusive option to license from the Cleveland Clinic a number of novel compounds. These compounds are currently in development at Cleveland Clinic as drug candidates for treatment of various cancers, designed to fight cancer based on stimulation of the immune system. In preclinical models, they have shown anti-cancer activity and a favourable toxicity profile as orally available agents.
› Verified 5 days ago
| Entity Name | Alleghany Highlands Community Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730136151 PECOS PAC ID: 0840392544 Enrollment ID: O20080408000854 |
News Archive
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB: RMCP), producers of the Rev Vac safety syringe, today announced that it has engaged Cirrus Financial Communications, LLC ("Cirrus") to provide comprehensive financial marketing and investor relations services.
Eye research charity Fight for Sight is partnering with the Stroke Association to test the effectiveness of a treatment for ‘retraining' the eyes for people who experience a loss of vision after stroke. The study hopes to establish a new standard of care for stroke survivors and save the NHS money.
APEIRON Biologics AG announced that it has entered into an exclusive option to license from the Cleveland Clinic a number of novel compounds. These compounds are currently in development at Cleveland Clinic as drug candidates for treatment of various cancers, designed to fight cancer based on stimulation of the immune system. In preclinical models, they have shown anti-cancer activity and a favourable toxicity profile as orally available agents.
› Verified 5 days ago
| Entity Name | Mental Wellness Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760860936 PECOS PAC ID: 8729394762 Enrollment ID: O20150904001560 |
News Archive
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB: RMCP), producers of the Rev Vac safety syringe, today announced that it has engaged Cirrus Financial Communications, LLC ("Cirrus") to provide comprehensive financial marketing and investor relations services.
Eye research charity Fight for Sight is partnering with the Stroke Association to test the effectiveness of a treatment for ‘retraining' the eyes for people who experience a loss of vision after stroke. The study hopes to establish a new standard of care for stroke survivors and save the NHS money.
APEIRON Biologics AG announced that it has entered into an exclusive option to license from the Cleveland Clinic a number of novel compounds. These compounds are currently in development at Cleveland Clinic as drug candidates for treatment of various cancers, designed to fight cancer based on stimulation of the immune system. In preclinical models, they have shown anti-cancer activity and a favourable toxicity profile as orally available agents.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Malak Waheb Yossef Iskandar, DO Po Box 20867, Roanoke, VA 24018-0526 Ph: (540) 427-7944 | Dr Malak Waheb Yossef Iskandar, DO 3959 Electric Rd Ste 280, Roanoke, VA 24018-4572 Ph: (540) 427-7944 |
News Archive
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB: RMCP), producers of the Rev Vac safety syringe, today announced that it has engaged Cirrus Financial Communications, LLC ("Cirrus") to provide comprehensive financial marketing and investor relations services.
Eye research charity Fight for Sight is partnering with the Stroke Association to test the effectiveness of a treatment for ‘retraining' the eyes for people who experience a loss of vision after stroke. The study hopes to establish a new standard of care for stroke survivors and save the NHS money.
APEIRON Biologics AG announced that it has entered into an exclusive option to license from the Cleveland Clinic a number of novel compounds. These compounds are currently in development at Cleveland Clinic as drug candidates for treatment of various cancers, designed to fight cancer based on stimulation of the immune system. In preclinical models, they have shown anti-cancer activity and a favourable toxicity profile as orally available agents.
› Verified 5 days ago
Dr. Badr Ratnakaran, MBBS Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2017 Jefferson St Sw, Roanoke, VA 24014 Phone: 540-981-8025 Fax: 540-853-0511 | |
Carlos Mora, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3 Riverside Cir, Roanoke, VA 24016 Phone: 540-224-5170 Fax: 540-985-9427 | |
John H Draeger, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2017 Jefferson St Sw, Roanoke, VA 24014 Phone: 540-853-0900 Fax: 540-853-0518 | |
Fahim Fahim, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3517 Brandon Ave Sw, Roanoke, VA 24018 Phone: 540-981-1102 Fax: 540-344-4169 | |
Dr. John Eric Vance, M.D Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2017 Jefferson St Sw, Roanoke, VA 24014 Phone: 540-853-0900 Fax: 540-853-0518 | |
Dr. John Gordon Burch, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4431 Starkey Rd, Roanoke, VA 24018 Phone: 540-342-0211 Fax: 540-344-5543 | |
Sooraj John, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2017 Jefferson St Sw, Roanoke, VA 24014 Phone: 540-981-8025 Fax: 540-853-0511 |